Orelabrutinib is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).
Cas No.
1655504-04-3
分子式
C26H25N3O3
分子量
427.5
别名
ICP-022;Orelabrutinib
参考文献
[1]Wei Xu, et al. Safety, Tolerability and Efficacy of Orelabrutinib, Once a Day, to Treat Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia. Blood (2019) 134 (Supplement_1): 4319.
储存和溶解度
DMSO:250 mg/mL (584.80 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years